Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @FrancineLane
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FrancineLane
-
Francine Lane proslijedio/la je Tweet
Global
#clinicaltrial recruitment rates have been on the rise over the past seven years, thanks to new techniques designed to make patient participation easier, but the benefits have not translated to patient retention, according to a new study. http://ow.ly/NibB50ybUlI pic.twitter.com/KoIBi6IoOW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Check out the first in an 8-part series on
#clinicaltrial transparency policies, by Thomas Wicks, Chief Strategy officer.@ThomasWicksPCM http://ow.ly/VEeh50y7d7p pic.twitter.com/GSnornsCCZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
The degree of digital
#healthliteracy – of physicians, patients, institutions and payers – can really make the difference between an efficient integration and a missed opportunity, says one#healthcare communications professional.http://ow.ly/QhF050y0599Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Failure to report
#clinicaltrial results on http://ow.ly/nAQy50xZV1s distorts evidence, breaches ethical obligations, and represents research waste. See how industry/non-industry, large/small sponsors fared in this comprehensive study.@bengoldacre http://ow.ly/cRwO50xZV1r pic.twitter.com/ijnFir2fKn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
#Clinicaltrial transparency still eludes the system in India, especially for the patient, says the president of the Indian Society for Clinical Research and advocacy groups.http://ow.ly/URfv50xZXNpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Penn State Cancer Institute researchers analyzed data from over 12 million patients with 46 different types of cancer between 2004 and 2015. They found that only 0.1% were enrolled in
#clinicaltrials as their first course of therapy following diagnosis.http://ow.ly/CsKN50y0aBDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Australia's University of the Sunshine Coast (USC) has received a $10,000 grant from the Association of Regulatory and Clinical Scientists (ARCS) to conduct a study for creation of a consumer confidence index for the clinical trials industry.http://ow.ly/fon050xRAZD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Join us, along with EMD Serono - the North America biopharma business of Merck KGaA, Darmstadt, Germany - and CISCRP, for a webinar on how to successfully launch a dedicated
#clinicaltrials website.@EMDSerono@CISCRP Register now:http://ow.ly/lhwU50xPtOAHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
#Clinicaltrials are a valuable but often misunderstood part of healthcare, and a stigma still surrounds trials. Who's qualified, risks, costs, length and what's in it for me are the top questions patients ask before deciding whether to participate. http://ow.ly/naaZ50xP2Gr pic.twitter.com/ze8TeNoS0E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
In a joint letter from 33 organizations to the European Medicines Agency, the European Public Health Alliance seeks protection of public access to
#clinicaltrial results. "Full#transparency – not secrecy – is the way forward!"@EMA_News@EPHA_EUhttp://ow.ly/uKbM50xEhO6Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
In
#clinicaltrials first-in-class medicines are typically brought to market based on data from majority white, male patients. Among the 53 drugs with U.S. clinical trials in 2018, only 12 had enough data on effects across races, FDA's Snapshots reports. http://ow.ly/wHmJ50xBkXz pic.twitter.com/khKZj6pQUy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
We join the International Alliance of Patients’ Organizations (IAPO) in celebrating the 7th annual Patient Solidarity Day. Each year, concerned people worldwide rally around and raise awareness for an issue impacting
#patients and their families.@IAPOvoice#PSD2019pic.twitter.com/cAapdbWSnH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
TrialScope%20Launches%20Clinical%20Trials%20Website%20For%20EMD%20Serono https%3A%2F%http://2Fwww.clinicalleader.com %2Fdoc%2Ftrialscope-launches-clinical-trials-website-for-emd-serono-0001
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Look for Dave Laky and Lauren Briggs at the DIA Clinical Trial Regulation Conference in Amsterdam. They can answer your questions about clinical trial transparency and disclosure management.
#clinicaltrials@DrugInfoAssnpic.twitter.com/geUOi7hwud
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
According to TrialScope’s 2019 Global Clinical Trial Disclosure & Transparency Benchmark Survey, sponsors' 2020 disclosure priorities are PLS, followed by the new EU Portal,
#clinicaltrial results,#datasharing and#patientengagement https://resources.trialscope.com/newsroom/trialscope-releases-global-clinical-trial-disclosure-survey-results?utm_source=SM-Twitter-Organic&utm_medium=Social-Organic&utm_campaign=TrialScope-Website&utm_content=2019-11-25 …pic.twitter.com/w0lyyXlCA5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
The US isn't the only country with gender disparities in
#clinicaltrials - Australian research ignores drugs’ side effects in women. Clinical trials there often fail to report results for sex and gender, although many drugs cause adverse effects in women. http://ow.ly/bTky50xklkv pic.twitter.com/Bwcj3ilRf3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
Attending the
@DrugInfoAssn#clinicaltrial conferences Dec. 2-5 in Amsterdam? Look for Dave Laky and Lauren Briggs, who will be on hand to answer your questions about automating clinical trial disclosure and making studies more accessible to patients.pic.twitter.com/fhcH9p895N
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
A new report shows slow progress in reporting
#clinicaltrial results on CTgov, but data quality still may present a larger problem. Ex-CTgov head Dr. Deborah Zarin shared details of the report at our recent EXTRA: TrialScope Transparency Experience. http://ow.ly/DHmu50xb78Z pic.twitter.com/mjGOt2Yb2w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
The NIH has released a draft policy requiring all investigators with NIH funding to make their data sets available to colleagues. For the first time, grantees holding any NIH-funded grant will need to submit a detailed plan for sharing data.
#datasharinghttp://ow.ly/R1kA50x8NbRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Francine Lane proslijedio/la je Tweet
In a Forbes article, TrialScope CEO Jeff Kozloff gives 5 compelling reasons why transparency is good business. For starters,
#transparency puts your company in a favorable light with investors.@jeffkozloff@ForbesTechCncl Read all 5 reasons here:http://ow.ly/zGpR50x1etdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.